Interact to see
Advertisement
Advertisement
CMRCX vs MERFX
CMRCX vs MERFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
CMRCX vs. MERFX commentary
Aug 19, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMRCX is a Buy and MERFX is a Hold.
FUNDAMENTALS
Fundamentals
MERFX has more cash in the bank: 2.39B vs. CMRCX (2.6M). MERFX pays higher dividends than CMRCX: MERFX (1.65) vs CMRCX (0.40). CMRCX was incepted earlier than MERFX: CMRCX (2 years) vs MERFX (37 years). CMRCX (13.31) is less costly to investors than MERFX (1.67). MERFX is a more actively managed with annual turnover of: 153.00 vs. CMRCX (136.00). CMRCX (2500) and MERFX (2500) have matching initial minimum investment requirements. CMRCX annual gain was more profitable for investors over the last year : 6.09 vs. MERFX (5.24).
| CMRCX | MERFX | CMRCX / MERFX | |
| Total Expense Ratio | 2.91 | 1.56 | 187% |
| Annual Report Gross Expense Ratio | 13.31 | 1.67 | 797% |
| Fund Existence | 2 years | 37 years | - |
| Gain YTD | 6.599 | 5.834 | 113% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 2500 | 2500 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.6M | 2.39B | 0% |
| Annual Yield % from dividends | 0.40 | 1.65 | 24% |
| Returns for 1 year | 6.09 | 5.24 | 116% |
| Returns for 3 years | N/A | 9.20 | - |
| Returns for 5 years | N/A | 10.48 | - |
| Returns for 10 years | -54.78 | 24.85 | -220% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GAGEX | 23.48 | 0.06 | +0.26% |
| Guinness Atkinson Global Energy | |||
| FCUIX | 20.41 | 0.03 | +0.15% |
| NYLI PineStone U.S. Equity Class I | |||
| ACSLX | 97.92 | -0.32 | -0.33% |
| American Century Select C | |||
| MUSEX | 39.98 | -0.14 | -0.35% |
| MFS Blended Research Core Equity I | |||
| FRSLX | 26.87 | -0.10 | -0.37% |
| Nuveen Small/Mid Cap Growth Opp A | |||